Drug intelligence / Profile preview

Holcus lanatus pollen extract

Development stage
Unknown
Lead developer
ALK Abelló
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Sublingual, Intradermal
01

Overview

Holcus lanatus pollen extract is an allergenic extract derived from the pollen of the Holcus lanatus plant, which is also known as Yorkshire Fog or velvet grass. Developed and marketed by ALK-Abelló, Inc., it is classified as a non-standardized, biological product. This extract is utilized for both diagnostic and therapeutic purposes. For diagnosis, it is administered via percutaneous or intradermal skin tests to identify sensitivity to velvetgrass pollen. Therapeutically, it is used in allergen immunotherapy (hyposensitization) to treat allergic rhinitis and rhino-conjunctivitis. This treatment involves administering gradually increasing doses of the allergen to desensitize the immune system, thereby building tolerance and reducing allergic symptoms. The extract is formulated as an injection solution and has been on the market since 1965.

Other names
Yorkshire Fog grass pollen extractvelvet grass pollen extract
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Holcus lanatus pollen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Holcus lanatus pollen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call